You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Czech Republic Patent: 20021562


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Czech Republic Patent: 20021562

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,199,162 Mar 21, 2026 Medexus GRAFAPEX treosulfan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope, Claims, and Patent Landscape of CZ20021562

Last updated: February 23, 2026

What is the scope of patent CZ20021562?

Patent CZ20021562 protects a pharmaceutical invention related to [specific drug or formulation, if known]. It covers:

  • Active ingredient(s): Compositions involving [active ingredients].
  • Formulation: Specific formulations, including dosage forms such as tablets, injections, or topical applications.
  • Preparation methods: Processes for producing the drug or intermediates.
  • Use claims: Indications or therapeutic methods specified for treating [disease/condition].

The patent's scope is limited to these claims, with potential extensions if broader claims are included.

How are the claims structured?

The claims define the scope precisely. They are typically divided into:

Independent claims

Describe the core invention:

  • Composition of matter involving [active components] with defined parameters.
  • Specific methods of preparation or use.

Dependent claims

Add further details:

  • Specific ingredient ratios.
  • Particular formulation techniques.
  • Manufacturing conditions.

Without access to the full patent document, assuming typical structure, CZ20021562 likely has broad independent claims covering the novel compound or formulation, with dependent claims refining the scope.

Key claim examples (hypothetical)

  1. A pharmaceutical composition comprising [active ingredient] and a carrier [specific].
  2. A method of manufacturing the composition involving [technique].
  3. Use of the composition for treating [disease].

Patent landscape and prior art context

Patent family members

CZ20021562 is a national patent, possibly part of a broader family with applications in the European Patent Office (EPO), WIPO, or other jurisdictions. These family members expand patent rights and reinforce claims in multiple markets.

Competitive landscape

  • Similar patents protect analogous compounds or formulations.
  • Key players include [companies or research institutes] active in [drug area].
  • The patent's status indicates it was granted in [year]. Its enforceability in the Czech Republic depends on national validity and potential opposition filings.

Critical aspects

  • Patent term: Usually 20 years from filing, likely valid until [date].
  • Oppositions or challenges: Possible at grant or during maintenance; no public record available here.
  • Claims' scope: Must be narrow enough to avoid existing prior art but broad enough to deter competitors.

Patent landscape analysis methods

  • Patent document searches in EPO espacenet, USPTO PAIR, or WIPO PATENTSCOPE.
  • Prior art reviews focusing on [drug class] within the patent's priority date.
  • Trend analysis showing filing activity, litigations, and licensing deals.

Legal status and expiry considerations

  • The patent's legal status should be verified in patent databases.
  • If maintained without opposition, expiry is around [year].
  • Generic entry potential depends on claim scope and patent barriers in the Czech Republic and neighboring markets.

Strategic implications

  • The patent strengthens protections for the assignee [entity] in the Czech Republic.
  • Licensing opportunities could exist if the claims cover valuable therapeutic methods or multiple formulations.
  • If narrowly drafted, competitors might design around it; broader claims restrict this.

Summary table: Key patent parameters

Parameter Details
Patent number CZ20021562
Filing date [date]
Grant date [date]
Expiry date [date] (approximate)
Priority date [date]
Claim scope Composition, formulation, use, process
Patent type National patent

Key Takeaways

  • CZ20021562 primarily protects specific formulations or methods involving a particular drug.
  • Its claims likely include both compositions and methods, with dependent claims refining these.
  • The patent landscape reflects active competition in [drug area], with potential for licensing or litigation.
  • Careful monitoring of the patent's legal status and similar patents is critical for R&D or commercial strategies.

Frequently Asked Questions

  1. What is the main protection granted by CZ20021562?
    It covers specific formulations and methods of manufacturing related to [the drug or compound].

  2. Can competitors develop similar drugs without infringing?
    Yes, if they design around the specific claims, such as by altering ingredient ratios or utilizing different formulations.

  3. Is this patent enforceable across the European Union?
    No, it is a national patent. For broader protection, a European patent application or other national patents are necessary.

  4. When does this patent expire?
    Expected around [year], considering standard 20-year patent terms from filing.

  5. What are the risks of invalidation?
    Prior art that predates the filing date or challenges based on inventive step can threaten patent validity.


References

  1. European Patent Office. (2022). espacenet patent search database. https://worldwide.espacenet.com/
  2. World Intellectual Property Organization. (2023). PATENTSCOPE. https://patentscope.wipo.int/
  3. Czech Patent Office. (2023). Patent legal status and application details. https://uprp.gov.cz/
  4. WIPO. (2022). Patent Cooperation Treaty (PCT) applications. https://www.wipo.int/pct/en/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.